Back in April 2022, we hosted an Advocacy in Action LinkedIn livestream demystifying the complex topic “national pharmacare” for the public and other interested stakeholders. We anticipate progress on both Pharmacare and a Rare Diseases Strategy as 2023 approaches, so the time is right for the pharmacy sector to get informed and engaged in the conversation. Our November 1 Advocacy in Action LinkedIn livestream revisited this conversation and further discussed the key impacts pharmacare and other policies might have on community pharmacy.
